All Type of News
Daewoong faces lawsuit
Daewoong Pharm faces a lawsuit as Yuyu Pharm has recently filed a compensation suit against Daewoong for breaking a contract to produce a generic version of Lanston, anti-ulcer agent.
The Seoul Central District Cou...
Government likely to restrict co-bioequivalence testing
The restriction of joint or consigned bioequivalence testing will not be lifted, according to informed sources.
The sources say the Korea Food and Drug Administration will determine the delay or abolition of the is...
HIRA loose on monitoring of healthcare institutions
The Health Insurance Review and Assessment Service has neglected its duty in monitoring medical institutions, taking no follow-up measures against overcharging cases, the National Assembly Research Service said in its...
Philips to strengthen home healthcare business
Royal Philips Electronics (Philips) of the Netherlands says it will reinforce its home healthcare business for active aging to help protect the health and safety of the active aging population.
Active aging is def...
Hemorrhoid on increase
The National Health Insurance Corporation (NHIC) says the number of people suffering from hemorrhoid who visited hospitals was 214,100 last year.
Last year, 205,095 people had their senile cataract treatment cover...
Government to sustain tax breaks for facility investment
The government plans to extend 7% tax reduction on pharmaceutical facility investment of pharmaceutical by 2013, while local logistics tax benefits will be also extended to 2012.
The proposed revision, subject to p...
Government is unlikely to introduce for-profit hospital
Chin Soo-hee, nominee for health and welfare minister, drew a clear line between for-profit hospitals and their effect on attracting foreign medical tourists to the country, saying she won't push "privatization" of th...
Health ministry should let loose drugmakers
The National Assembly Research Service (NARS) said on August 23 that the Health Ministry's regulations concerning rebate provisions are impeding fair competition, demanding more flexible implementation of the current ...
Local leading drugmakers at crossroad
Prospects have been grim for Korean pharmaceutical companies, as they are getting pressed by multinationals' increasing market presence and the government's pressure to lower drug costs, such as a cash incentive plan ...
KFDA seeks to prevent abuse of propofol
The Korean Food and Drug Administration will discuss whether to designate propofol as a narcotic at a special review committee scheduled at the end of this month, officials said.
Despite such abuse potential, propo...
